Author:
Yan Min,Schwaederle Maria,Arguello David,Millis Sherri Z.,Gatalica Zoran,Kurzrock Razelle
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., … Ward, C. W. (2003). The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Molecular Cell, 11(2), 495–505.
2. Graus-Porta, D., Beerli, R. R., Daly, J. M., & Hynes, N. E. (1997). ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. The EMBO Journal, 16(7), 1647–1655. doi: 10.1093/emboj/16.7.1647 .
3. Holbro, T., Beerli, R. R., Maurer, F., Koziczak, M., Barbas, C. F., 3rd, & Hynes, N. E. (2003). The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proceedings of the National Academy of Sciences of the United States of America, 100(15), 8933–8938. doi: 10.1073/pnas.1537685100 .
4. Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., & Aaronson, S. A. (1987). erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science (New York, N.Y.), 237(4811), 178–182.
5. Ursini-Siegel, J., Schade, B., Cardiff, R. D., & Muller, W. J. (2007). Insights from transgenic mouse models of ERBB2-induced breast cancer. Nature reviews. Cancer, 7(5), 389–397. doi: 10.1038/nrc2127 .
Cited by
343 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献